Evidence that phosphorylation by the mitotic kinase Cdk1 promotes ICER monoubiquitination and nuclear delocalization

Experimental Cell Research

Volumn 317, Issue 17, 2011, Pages 2490-2502

  Mémin, Elisabeth ^b   Genzale, Megan ^b   Crow, Marni ^a   Molina, Carlos A ^a  

^a MONTCLAIR STATE UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cdk1; ICER; Phosphorylation; Ubiquitination

Indexed keywords

ALPHA TUBULIN; CYCLIN A; CYCLIN DEPENDENT KINASE 1; PROTEIN ICER; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; MALE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; UBIQUITINATION;

EID: 80052619768     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.07.001     Document Type: Article

References (42)

1. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2001, 2(1):21-32.
2. Yehia G., Razavi R., Memin E., Schlotter F., Molina C.A. The expression of inducible cAMP early repressor (ICER) is altered in prostate cancer cells and reverses the transformed phenotype of the LNCaP prostate tumor cell line. Cancer Res. 2001, 61(16):6055-6059.
3. Memin E., Yehia G., Razavi R., Molina C.A. ICER reverses tumorigenesis of rat prostate tumor cells without affecting cell growth. Prostate 2002, 53(3):225-231.
4. Razavi R., Ramos J.A., Yehia G., Schlotter F., Molina C.A. ICER-IIg is a tumor suppressor that mediates the antiproliferative activity of cAMP. Oncogene 1998, 17(23):3015-3019.
5. Lamas M., Molina C., Foulkes N.S., Jansen E., Sassone-Corsi P. Ectopic ICER expression in pituitary corticotroph AtT20 cells: effects on morphology, cell cycle, and hormonal production. Mol. Endocrinol. 1997, 11(10):1425-1434.
6. Servillo G., Della Fazia M.A., Sassone-Corsi P. Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp. Cell Res. 2002, 275(2):143-154.
7. Parvatiyar K., Harhaj E.W. Anchors away for ubiquitin chains. Science 2010, 328:1244-1245.
8. Folco E.J., Gideon K. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem. J. 1997, 328(1):37-43.
9. Pati D., Meistrich M.L., Plon S.E. Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis. Mol. Cell. Biol. 1999, 19(7):5001-5013.
10. Yehia G., Schlotter F., Razavi R., Alessandrini A., Molina C.A. MAP kinase phosphorylates and targets inducible cAMP early repressor to ubiquitin-mediated destruction. J. Biol. Chem. 2001, 276(38):35272-35279.
11. Hsiang C.Y., Wu S.L., Ho T.Y. Activation of activator protein 1 and extracellular signal-regulated kinases in human hepatocellular transformation. Tumor Biol. 2004, 25(5-6):313-320.
12. Sebolt-Leopold J.S., Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 2004, 4(12):937-947.
13. Miki T., Nonomura N., Nozawa M., Harada Y., Nishimura K., Kojima Y., Takahara S., Okuyama A. Angiogenesis inhibitor tnp-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line. J. Urol. 1998, 160(1):210-213.
14. Fuchs S.Y., Xie B., Adler V., Fried V.A., Davis R.J., Ronai Z. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors. J. Biol. Chem. 1997, 272(51):32163-32168.
15. Fimia G.M., De Cesare D., Sassone-Corsi P. CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature 1999, 398(6723):165-169.
16. de Groot R.P., Derua R., Goris J., Sassone-Corsi P. Phosphorylation and negative regulation of the transcriptional activator CREM by p34cdc2. Mol. Endocrinol. 1993, 7(11):1495-1505.
17. Nigg E.A. The substrates of cdc2 kinase. Semin. Cell Biol. 1991, 2(4):261-270.
18. Shah O.J., Ghosh S., Hunter T. Mitotic regulation of ribosomal S6 kinase 1 involves Ser/Thr, pro phosphorylation of consensus and non-consensus sites by Cdc2. J. Biol. Chem. 2003, 278(18):16433-16442.
19. Molina C.A., Foulkes N.S., Lalli E., Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 1993, 75(5):875-886.
20. Peter M., Nakagawa J., Doree M., Labbe J.C., Nigg E.A. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 1990, 60(5):791-801.
21. Dunphy W.G., Kumagai A. The cdc25 protein contains an intrinsic phosphatase activity. Cell 1991, 67(1):189-196.
22. Winget J.M., Mayor T. The diversity of ubiquitin recognition: hot spots and varied specificity. Mol. Cell 2010, 38:627-635.
23. Conaway R.C., Brower C.S., Conaway J.W. Emerging roles of ubiquitin in transcription regulation. Science 2002, 296(5571):1254-1258.
24. Hodges M., Tissot C., Freemont P.S. Protein regulation: tag wrestling with relatives of ubiquitin. Curr. Biol. 1998, 8(21):R749-R752.
25. McKinsey T.A., Zhang C.L., Olson E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(26):14400-14405.
26. Miller M., Reddy B.A., Kloc M., Li X.X., Dreyer C., Etkin L.D. The nuclear-cytoplasmic distribution of the Xenopus nuclear factor, xnf7, coincides with its state of phosphorylation during early development. Development 1991, 113(2):569-575.
27. Fabbro M., Henderson B.R. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 2003, 282(2):59-69.
28. Martinez-Balbas M.A., Dey A., Rabindran S.K., Ozato K., Wu C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 1995, 83(1):29-38.
29. Hershkovitz M., Riggs A.D. Metaphase chromosome analysis by ligation-mediated PCR: heritable chromatin structure and a comparison of active and inactive X chromosomes. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(6):2379-2383.
30. Segil N., Guermah M., Hoffmann A., Roeder R.G., Heintz N. Mitotic regulation of TFIID: inhibition of activator-dependent transcription and changes in subcellular localization. Genes Dev. 1996, 10(19):2389-2400.
31. Desdouets C., Matesic G., Molina C.A., Foulkes N.S., Sassone-Corsi P., Brechot C., Sobczak-Thepot J. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol. Cell. Biol. 1995, 15(6):3301-3309.
32. Muniz L., Yehia G., Memin E., Pillarisetty R., Molina C.A. Transcriptional regulation of cyclin D2 by the PKA pathway and inducible cAMP early repressor in granulosa cells1. Biol. Reprod. 2006, 75:279-288.
33. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302(5652):1972-1975.
34. Chen Y., Chen C.F., Riley D.J., Allred D.C., Chen P.L., Von Hoff D., Osborne C.K., Lee W.H. Aberrant subcellular localization of BRCA1 in breast cancer. Science 1995, 270(5237):789-791.
35. Taylor J., Lymboura M., Pace P.E., A'Hern R.P., Desai A.J., Shousha S., Coombes R.C., Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer 1998, 79(4):334-342.
36. Wang W., Xue Y., Zhou S., Kuo A., Cairns B.R., Crabtree G.R. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 1996, 10(17):2117-2130.
37. Craig E., Zhang Z.K., Davies K.P., Kalpana G.V. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. EMBO J. 2002, 21(1-2):31-42.
38. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., Slingerland J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 2002, 8(10):1153-1160.
39. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., Arteaga C.L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 2002, 8(10):1145-1152.
40. Viglietto G., Motti M.L., Fusco A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 2002, 1(6):394-400.
41. Vaeth M., Gogishvili T., Bopp T., Klein M., Berberich-Siebelt F., Gattenloehner S., Avots A., Sparwasser T., Grebe N., Schmitt E., Hünig T., Serfling E., Bodor J. Regulatory T cells induce the nuclear accumulation of ICER/CREM and suppress the induction of NFATc1 in conventional CD4+ T cells. PNAS 2011, 108:2480-2485.
42. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.